Should add that ACE-inhibitors are effective anti-hypertensives in diabetics in not negatively affecting the insulin resistance of Type 2 diabetes.
There is this summary from NLibMed, not in re: diabetes, but relative to ACE inhibitors and ARBs vs. Covid. Review results are inconsistent
https://pubmed.ncbi.nlm.nih.gov/32320478/
Got it. Thanks for the ref.